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background: The clinical impact of tissue protrusion (TP) after stent implantation on long-term follow-up has not been fully elucidated.
Methods: ADAPT-DES was a prospective multicenter study of 8,582 pts undergoing percutaneous coronary intervention (PCI) using drug-eluting 
stents. In a pre-specified intravascular ultrasound (IVUS) substudy, 2,072 pts with 2,446 culprit lesions had post-PCI IVUS and were classified 
according to the presence or absence of post-stent TP.
results: After PCI, 840/2,446 culprit lesions (34.3%) had TP. Median [IQR] max TP was 0.7 [0.5, 1.5] mm2 in area and 3.0 [1.4, 6.7] mm in 
length. In 894 culprit lesions that were also examined by pre-PCI IVUS, TP was associated with larger proximal reference lumen area, greater plaque 
burden, and more plaque ruptures, attenuated plaque, and VH-thin cap fibroatheromas (TCFA). Because a larger stent or post-dilation balloon was 
used, post-PCI lumen area was significantly larger in lesions with vs. those without TP. At 2-year follow-up, there was less clinically driven target lesion 
revascularization (TLR) in patients with TP and no significant difference in incidence of major adverse cardiac events (MACE) (cardiac death, MI, or 
stent thrombosis) in pts with vs without TP.
conclusion: TP after PCI may not be associated with worse long-term clinical outcomes, in part to greater stent expansion in lesions with TP.
Table
TP group Non-TP group p-value
Pre-PCI IVUS N=335 lesions N=559 lesions
Plaque rupture 48.7% (163) 24.3% (136) <0.0001
Attenuated plaque 70.1% (235) 58.7% (328) 0.0006
VH-TCFA 61.8% (207) 45.8% (256) <0.0001
Proximal reference lumen area, mm2 11.3±4.4 9.9±4.0 0.0003
Percent plaque volume, % 59.8 ± 8.6 55.7 ± 9.1 <0.0001
Remodeling index 1.05 ± 0.42 0.99 ± 0.36 0.05
Post-PCI IVUS N=840 lesions N=1606 lesions
MLA, mm2 6.7 ± 2.5 6.0 ± 2.3 <0.0001
Mean lumen area, mm3/mm 8.3 ± 2.7 7.4 ± 2.5 <0.0001
Minimum stent area (MSA), mm2 6.8 ± 2.6 6.0 ± 2.3 <0.0001
Stent expansion (=MSA/reference lumen area), % 76.8 ± 19.6 72.9 ± 16.8 <0.0001
Patient level N=797 patients N=1275 patients
Max device diameter, mm 3.41 ± 0.65 3.25 ± 0.61 <0.0001
Max balloon pressure, atm 16.0 ± 3.7 15.8 ± 3.9 0.12
MACE through 2 years 4.20% (33) 4.78% (59) 0.61
Periprocedural MI 1.76% (14) 0.94% (12) 0.10
Non-Periprocedural MI 1.41% (11) 2.31% (28) 0.18
Stent thrombosis 0.75% (6) 0.48% (6) 0.41
Clinically driven TLR 3.26% (26) 5.10% (65) 0.047
